Blog

Transforming MDD Symptom Management with a Digital Therapeutic

Discover Rejoyn®, the first FDA-authorized prescription digital treatment as an adjunct to ADT for adult patients with MDD. This smartphone-delivered intervention offers psychiatrists a different approach to offer their appropriate patients that can help treat MDD symptoms. The intended audience for this program is healthcare professionals involved in the treatment of patients with MDD. See the Clinician Brief Summary at rejoynhcp.com